Showing results (331-340 of 362) with videos related to

Sort By:
Pageof 37
ACS Medicinal Chemistry Letters|January 16, 2015
Pyrimidine-based tricyclic molecules as potent and orally efficacious inhibitors of wee1 kinaseYunsong Tong, Maricel Torrent, Alan S Florjancic, et al.
BMC Cancer|September 8, 2009
Reversal of oncogene transformation and suppression of tumor growth by the novel IGF1R kinase inhibitor A-928605William N Pappano, Paul M Jung, Jonathan A Meulbroek, et al.
Nature Cancer|September 27, 2021
Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degradersXuewei Wu, Xiaobao Yang, Yan Xiong, et al.
Molecular Cancer Therapeutics|March 4, 2015
Characterization of ABT-806, a Humanized Tumor-Specific Anti-EGFR Monoclonal AntibodyEdward B Reilly, Andrew C Phillips, Fritz G Buchanan, et al.
Nature Communications|May 6, 2026
Discovery of a paralog-selective p300 protein degrader with potent anti-cancer activity in hematological malignanciesMarwa S Asem, Yan Zhai, Xiaohong Song, et al.
Blood|January 31, 2023
Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemiaStephen K Tahir, Emiliano Calvo, Benedito A Carneiro, et al.
The Journal of Biological Chemistry|October 28, 2004
A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinaseShane Atwell, Jason M Adams, John Badger, et al.
European Journal of Dental Education : Official Journal of the Association for Dental Education in Europe|June 8, 2018
Oral Medicine for undergraduate dental students in the United Kingdom and Ireland-A curriculumA J Mighell, C Freeman, P A Atkin, et al.
Pageof 37